Jump to content
Powered by

Latest news

Here you can find the latest articles about the Baden-Württemberg healthcare industry.

  • Article - 08/12/2015

    Apoptotic processes, i.e. cell death mediated by intracellular programmes, have been implicated in a variety of diseases. Apoptotic processes eliminate superfluous or irreparably damaged cells from the body; however, defective apoptotic processes harm the organism. New research results show that processes at the mitochondrial membrane might be excellent targets for pharmaceutical interference with apoptosis.

  • Article - 07/12/2015

    It starts with memory loss and disorientation. Alzheimer’s disease is the most common type of dementia and is characterised by the loss of neurons and synapses in the brain resulting from the aggregation of beta amyloid protein fragments into fibrils and plaques. Prof. Dr. Knut Biber and his team from the Division of Molecular Psychiatry at Freiburg University Medical Center have analysed these plaques in an in vivo-like cell culture system. They…

  • Article - 04/12/2015

    Dr. Philipp Berens from the Bernstein Center for Computational Neuroscience at the University of Tübingen uses computer models to study how light that enters the retina is turned into events that trigger nerve impulses. The bioinformatician has recently received the BMBF’s Bernstein Award for Computational Neuroscience.

  • Article - 02/12/2015

    The measurement of blood glucose levels reveals changes in foetal brain response after a pregnant woman has consumed glucose. The postprandial brain response generated by the unborn children of women with gestational diabetes differs from that of children of women without gestational diabetes. Researchers from Tübingen have been using magnetic encephalography to examine the effect of insulin on the brain and the relationships between gestational…

  • Article - 01/12/2015

    Modern IT solutions and the digital networking of devices and work processes permeate many areas of life, and this does not stop at hospital gates. A cooperative project, InnOPlan, coordinated by KARL STORZ GmbH & Co. KG in Tuttlingen, is studying data-driven optimisation of processes in operating theatres.

  • Article - 30/11/2015

    Dr. Bianca Hermann from the University of Freiburg specialises in multi-haem enzymes, and investigates the enzymes’ structure and reaction mechanisms. She has clarified the enzymes’ crystal structure and reaction mechanisms and found out why the bacterial MccA enzyme complex can reduce sulphur-containing substances such as sulphites up to a hundred times faster than other enzymes.

  • Article - 26/11/2015

    Chrystelle Mavoungou is a chemist who teaches regulatory affairs and quality in pharmaceutical production at the Biberach University of Applied Sciences’ Faculty of Biotechnology. While the public might consider these issues difficult to deal with, students and early career pharmaceutical biotechnologists quickly learn that issues like these take them right to the heart of the drug discovery process.

  • Article - 24/11/2015

    Around two thirds of people carry the JC polyomavirus, a normally harmless virus that, in immunocompromised patients, can evade the body’s defences and cause a fatal brain infection. An international research network has now found a way to activate the immune system and attack the virus.

  • Article - 23/11/2015

    Plants have sophisticated defence mechanisms to help them fight off all kinds of pathogens. A group of researchers led by Dr. Gabriel Schaaf at the University of Tübingen’s ZMBP has now discovered that plants’ immune response is more similar to the innate immune system of humans and animals than previously thought.

  • Article - 19/11/2015

    Scientists from the Hertie Institute for Clinical Brain Research at the University of Tübingen are pursuing an innovative treatment approach for Alzheimer’s disease using immune cells to eliminate the protein deposits that are the hallmark of Alzheimer’s. Dr. Jonas Neher and his team tested whether exchanging brain-specific immune cells with fresh, more active cells has a positive effect on the disease.

  • Article - 17/11/2015

    In the ”NanoBioMater”project house, researchers from the University of Stuttgart are working to develop novel hydrogels with integrated biocompatible scaffold structures. Their aim is to make the materials suitable for producing innovative components for environmental and food analytics as well as medical applications. The hydrogels could potentially be used in diagnostic biosensors and the controlled release of medical compounds.

  • Article - 16/11/2015

    Dr. Sylvia Erhardt from the ZMBH in Heidelberg is specifically focused on the function of the centromere, the part of the chromosome indispensable for correct segregation of the chromosomes during cell division. Malfunctioning centromeres lead to changes in chromosome number, which is a hallmark of many types of cancer.

Website address: https://www.gesundheitsindustrie-bw.de/en/article/news